Talphera (TLPH) EBT Margin Growth (5y) (2016 - 2025)
Talphera (TLPH) EBT Margin Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Talphera | 90.25 Mn | 90.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -35.60 Mn |
| Mar 31, 2025 | -620,040.00 |
| Dec 31, 2023 | 44,363.00 |
| Sep 30, 2023 | 209,425.00 |
| Jun 30, 2023 | -46,063.00 |
| Mar 31, 2023 | 249,293.00 |
| Mar 31, 2022 | -161,678.00 |
| Dec 31, 2021 | -39.57 Mn |
| Sep 30, 2021 | -15,284.00 |
| Jun 30, 2021 | -197,777.00 |
| Mar 31, 2021 | -154,273.00 |
| Dec 31, 2020 | -59,811.00 |
| Sep 30, 2020 | -69,064.00 |
| Jun 30, 2020 | 23,658.00 |
| Mar 31, 2020 | 119,519.00 |
| Dec 31, 2019 | 307,774.00 |
| Sep 30, 2019 | -210,782.00 |
| Jun 30, 2019 | 1.59 Mn |
| Mar 31, 2019 | 201,355.00 |
| Dec 31, 2018 | -206,029.00 |